<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1095">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05146895</url>
  </required_header>
  <id_info>
    <org_study_id>HH20190606</org_study_id>
    <nct_id>NCT05146895</nct_id>
  </id_info>
  <brief_title>A Cohort Study of Hyperthermia and Imiquimod for the Treatment of Flat Warts</brief_title>
  <official_title>Evaluation of Local Hyperthermia for the Treatment of Flat Warts After 4 Months: a Single-center, Single-blind, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Hospital of China Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Hospital of China Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      flat warts are a superficial viral skin disease, extremely common in childhood.Treatment of&#xD;
      warts is often difficult and involves different destructive procedures.Although several&#xD;
      pharmacological and physical topical treatments are available (keratolytic agents,&#xD;
      electrosurgery, cryotherapy, carbon dioxide laser), results are often unsatisfactory in terms&#xD;
      of efficacy (frequent recurrence) and cosmetic outcome (scars, inflammatory reactions,&#xD;
      transient or permanent hyper- or hypopigmentation).&#xD;
&#xD;
      Mild local Hyperthermia with a certain temperature range has been successfully used in the&#xD;
      treatment of some diseases. It has been utilised in the treatment of some neoplasm, fungal&#xD;
      and HPV infections. Investigators' study found that local hyperthermia at 44°C could cleared&#xD;
      HPV in more than half of the patients with plantar warts. Investigators also note the fact&#xD;
      that in patients with multiple lesions, the clearance of the target lesion is commonly&#xD;
      followed by clearance of other distant lesions, a phenomenon suggesting that local&#xD;
      hyperthermia could aid in establishing a specific immune response to eliminate HPV.So the&#xD;
      purpose of the study is to evaluation local hyperthermia in the treatment of flat warts&#xD;
      Appropriate control arms were designed for different conditions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 20, 2018</start_date>
  <completion_date type="Anticipated">June 20, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 20, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clearance rates of HPV</measure>
    <time_frame>3 months after the last time of treatment</time_frame>
    <description>to evaluate the clearance rates of all lesions in different treatment groups 3 month after treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>effective rates of HPV</measure>
    <time_frame>3 months after the last time of treatment</time_frame>
    <description>to evaluate the effective rates of all lesions in different treatment groups 3 month after treatment.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Human Papilloma Virus</condition>
  <arm_group>
    <arm_group_label>Local Hyperthermia at 44℃ for falt warts</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Local hyperthermia at 44℃ for 30 mins on one lesion region, at days of 1,2,3, 15, 16, 21 and 28.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Imiquimod for Flat Warts</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Miquimod treatment: 3 times a week for 1 month</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Imiquimod treatment</intervention_name>
    <description>As an control arm, for patients with flat warts</description>
    <arm_group_label>Imiquimod for Flat Warts</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Local Hyperthermia at 44℃</intervention_name>
    <description>As an experimental arm, for patients with flat warts</description>
    <arm_group_label>Local Hyperthermia at 44℃ for falt warts</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  12-65 years old;&#xD;
&#xD;
          -  diagnosis confirmed;&#xD;
&#xD;
          -  signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant woman;&#xD;
&#xD;
          -  Local or systematic treatment within 3 months;&#xD;
&#xD;
          -  Comorbidity of other severe gynecological inflammation,&#xD;
&#xD;
          -  Infection, or tumor;&#xD;
&#xD;
          -  Comorbidity of other serious illnesses;&#xD;
&#xD;
          -  No guarantee of timely treatment and follow-up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xinghua Gao</last_name>
    <phone>+86 139 4015 2467</phone>
    <email>gaobarry@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shengnan Zhao</last_name>
    <phone>+15104042205</phone>
    <email>zsn15104042205@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>the First Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>xinghua gao</last_name>
      <phone>13940152467</phone>
      <email>gaobarry@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 17, 2021</study_first_submitted>
  <study_first_submitted_qc>November 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 7, 2021</study_first_posted>
  <last_update_submitted>November 23, 2021</last_update_submitted>
  <last_update_submitted_qc>November 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Hospital of China Medical University</investigator_affiliation>
    <investigator_full_name>Gao Xinghua</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>hyperthermia</keyword>
  <keyword>human papillomavirus virus</keyword>
  <keyword>flat warts</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Papilloma</mesh_term>
    <mesh_term>Hyperthermia</mesh_term>
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Imiquimod</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

